FOLH1 and prostate carcinoma: Next, prostate cancer cells (LNCaP, 22Rv1, and PC-3) were spiked into 7.5 mL blood taken from healthy donors and processed using the CellSearch® system and addition of a FITC-labelled anti-PSMA antibody in the fourth fluorescence channel.